Tech Company Financing Transactions
Locate Bio Funding Round
On 4/29/2024, Locate Bio announced $11.5 million in financing from BGF Ventures, Mercia Ventures and private investors.
Transaction Overview
Company Name
Announced On
4/29/2024
Transaction Type
Venture Equity
Amount
$11,500,000
Round
Undisclosed
Investors
BGF Ventures (Lead Investor)
Mercia Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to further enhance its clinical study of LDGraft, a bone graft substitute for spinal fusion.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
MediCity Thane Road
Beeston Nottingham, NG90 6BH
UK
Beeston Nottingham, NG90 6BH
UK
Phone
Website
Email Address
Overview
LOCATE BIO is an innovative UK MedTech company with industry-leading drug delivery and tissue scaffold capabilities. We are focused on developing next-generation solutions that address unmet musculoskeletal needs. We are LOCATE BIO, and we are building next-generation products for surgeons, so they can relieve suffering and restore quality of life for the 1.7Bn people around the globe who suffer from musculoskeletal conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John von Benecke
Chief Financial Officer
Colin Thomson
Chief Scientific Officer
Kevin Shakesheff
VP - Regulatory Affairs
Robyn Cochrane
Browse more venture capital transactions:
Prev: 4/29/2024: BioIntelligence Technologies venture capital transaction
Next: 4/29/2024: Adaptilens venture capital transaction
Share this article
About Database of VC Transactions
We record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs